U.S. Patent and Trademark Office

In a significant legal triumph, BBK, the manufacturer of the renowned RAW rolling papers, secured a win on crucial legal points in its trademark dispute with Central Coast Agriculture, Inc. (CCA). The contention centered around CCA's employment of the "RAW GARDEN" name for its...

In parallel with working towards discovering and advancing therapeutic psychedelics, biopharma companies are continuously protecting their findings. The emerging biotech BetterLife Pharma Inc. (OTCQB: BETRF) has filed an international PCT along with a U.S. patent application for the...

The U.S. Patent and Trademark Office has granted Pharmather Holdings Ltd. (OTCQB: PHRRF) a patent for a ketamine production process. The patent, titled “Ketamine Flow Synthesis,” refers to a continuous-flow process technology for the preparation of ketamine and ketamine analogs. It...

Psychedelics company Cybin Inc. (NEO: CYBN) (AMEX: CYBN) announced that the U.S. Patent and Trademark Office has granted U.S. patent 11,242,318 to the company’s investigational deuterated dimethyltryptamine (“DMT”) compound CYB004. The allowed claims include a range of...

The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has affirmed three Medtronic plc (NYSE: MDT) patents related to its InterStim sacral neuromodulation device family challenged by Axonics Inc (NASDAQ: AXNX). These patents relate to...

Moderna Inc (NASDAQ: MRNA) has lost the bid to invalidate a key patent related to the development of several of its next-generation vaccines, including one meant for coronavirus, to Arbutus Biopharma Corp (NASDAQ: ABUS), Reuters reported. What Happened The Massachusetts-headquartered company...

Cesca Therapeutics Inc (NASDAQ: KOOL) shares have moved out of a one-year trading range of $2.50–$4 Tuesday and are currently at their highest level in over a year. The catalyst being an announcement from the company that the U.S. Patent and Trademark Office issuing a notice of allowance...

Axon Enterprise Inc (NASDAQ: AAXN) is undeterred by recent setbacks in the everlasting Digital Ally, Inc. (NASDAQ: DGLY) conflict. The U.S. Patent and Trademark Office denied Axon’s petitions for inter partes review of Digital Ally’s ‘452 patent in July, shortly after issuing Axon...

Friday morning saw the latest act play out in the ongoing legal drama between Axon Enterprise, Inc (NASDAQ: AAXN) and Digital Ally (NASDAQ: DGLY). Digital Ally announced that the U.S. Patent and Trademark Office (USPTO) denied Axon’s petition aimed at invalidating one of two Digital Ally...

Axon Enterprise Inc (NASDAQ: AAXN) and Digital Ally, Inc. (NASDAQ: DGLY) are nearly four years into an ongoing patent dispute, and ambiguity over continued litigation is meant to be settled with rulings from the U.S. Patent and Trademark Office. The district court judge overseeing the case had...

A U.S. Supreme Court ruling that allows trademarks to be as offensive as they want to be is good news for the Washington Redskins, which some people consider the epitome of repulsive team names. The high court Monday ruled unanimously that a law prohibiting the government from registering...

Wednesday morning, the United States Patent and Trademark Office’s Trademark Trial and Appeal Board ruled in favor of five Native Americans in the “Blackhorse v. Pro Football, Inc." decision, canceling the trademark of the name of the Washington Redskins. Washington will be...